{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T15:45:57Z","timestamp":1705592757001},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"19-20","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1007\/s00508-009-1250-3","type":"journal-article","created":{"date-parts":[[2009,11,17]],"date-time":"2009-11-17T12:30:01Z","timestamp":1258461001000},"page":"638-643","source":"Crossref","is-referenced-by-count":10,"title":["The EGF 61A\/G polymorphism \u2013 a predictive marker for recurrence of liver metastases from colorectal cancer"],"prefix":"10.1007","volume":"121","author":[{"given":"Florian M.","family":"Kovar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christiane","family":"Thallinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia L.","family":"Marsik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Perkmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald","family":"Puhalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helmuth","family":"Haslacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fritz","family":"Wrba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oswald F.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Gruenberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg","family":"Endler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"1250_CR1","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/01.sla.0000128305.90650.71","volume":"239","author":"EK Abdalla","year":"2004","unstructured":"Abdalla EK, Vauthey JN, Ellis LM, Ellis V, Pollock R, Broglio KR, et al (2004) Recurrence and outcome following hepatic resection, radiofrequency ablation, and combined resection\/ablation for colorectal liver metastases. Ann Surg 239: 818\u2013825, discussion 825\u2013827","journal-title":"Ann Surg"},{"key":"1250_CR2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3816\/CCC.2006.n.018","volume":"6","author":"AC Ashley","year":"2006","unstructured":"Ashley AC, Deschamps C, Alberts SR (2006) Impact of prognostic factors on clinical outcome after resection of colorectal pulmonary metastases. Clin Colorectal Cancer 6: 32\u201337","journal-title":"Clin Colorectal Cancer"},{"key":"1250_CR3","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s00508-005-0323-1","volume":"117","author":"Austrian Breast and Colorectal Cancer Study Group","year":"2004","unstructured":"Austrian Breast and Colorectal Cancer Study Group \u00d6GfCO, \u00d6sterreichische Gesellschaft f\u00fcr Chirurgie, \u00d6sterreichische Gesellschaft f\u00fcr H\u00e4matologie und Onkologie, \u00d6sterreichische Gesellschaft f\u00fcr Pathologie, \u00d6sterreichische Gesellschaft f\u00fcr Radioonkologie, Medizinische Strahlenphysik und Strahlenbiologie and \u00d6sterreichische R\u00f6ntgengesellschaft (2004) Empfehlungen zur Diagnostik und multimodaler Prim\u00e4rtherapie des Rektumkarzinoms. Wien Klin Wochenschr 117: 154\u2013171","journal-title":"Wien Klin Wochenschr"},{"issue":"Suppl","key":"1250_CR4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1634\/theoncologist.7-suppl_4-2","volume":"7","author":"J Baselga","year":"2002","unstructured":"Baselga J (2002) Why the epidermal growth factor receptor? The rationale for cancer therapy. Oncologist 7 [Suppl]: 2\u20138","journal-title":"Oncologist"},{"key":"1250_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08977190290022185","volume":"20","author":"AJ Danielsen","year":"2002","unstructured":"Danielsen AJ, Maihle N J (2002) The EGF\/ErB receptor family and apoptosis. Growth Factors 20: 1\u201315","journal-title":"Growth Factors"},{"issue":"Suppl","key":"1250_CR6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2165\/00003495-200060001-00002","volume":"60","author":"E Raymond","year":"2000","unstructured":"Raymond E, Faivre S, Armand JP (2000) Epidermal growth factor receptor tyrosine kinase as a target for anticancer therapy. Drugs 60 [Suppl]: 15\u201323, discussion 41\u201342","journal-title":"Drugs"},{"issue":"9304","key":"1250_CR7","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(02)07600-6","volume":"359","author":"M Shahbazi","year":"2002","unstructured":"Shahbazi M, Pravica V, Nasreen N, Fakhoury H, Fryer AA, Strange RC (2002) Association between functional polymorphism in EGF gene and malignant melanoma. Lancet 359 (9304): 397\u2013401","journal-title":"Lancet"},{"key":"1250_CR8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cancergencyto.2006.07.013","volume":"172","author":"E Vauleon","year":"2007","unstructured":"Vauleon E, Auger N, Benouaich A, Laigle-Donadey F, Kaloshi G, Lejeune J, et al (2007) The 61 A\/G EGF polymorphism is functional but is neither a prognostic marker nor a risk factor for glioblastoma. Cancer Genet Cytogenet 172: 33\u201337","journal-title":"Cancer Genet Cytogenet"},{"key":"1250_CR9","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1158\/0008-5472.CAN-03-3137","volume":"64","author":"DA Bhowmick","year":"2004","unstructured":"Bhowmick DA, Zhuang Z, Wait SD, Weil RJ (2004) A functional polymorphism in the EGF gene is found with increased frequency in glioblastoma multiforme patients and is associated with more aggressive disease. Cancer Research 64: 1220\u20131223","journal-title":"Cancer Research"},{"key":"1250_CR10","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1055-3207(02)00086-8","volume":"12","author":"RT Poon","year":"2003","unstructured":"Poon RT, Fan S (2003) Evaluation of the new AJCC\/UICC staging system for hepatocellular carcinoma after resection in Chinese patients. Surg Oncol Clin N Am 12: 35\u201360","journal-title":"Surg Oncol Clin N Am"},{"key":"1250_CR11","doi-asserted-by":"crossref","unstructured":"The Brisbane 2000 Terminology of Liver Anatomy and Resections (2000) HPB 2: 333\u2013339, HPB (Oxford) 2002, 4: 99\u2013100","DOI":"10.1080\/136518202760378489"},{"key":"1250_CR12","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1038\/sj.jid.5700377","volume":"126","author":"I Okamoto","year":"2006","unstructured":"Okamoto I, Roka F, Kr\u00f6gler J, Endler G, Kaufmann S, Tockner S, et al (2006) The EGF A61G polymorphism is associated with disease-free period and survival in malignant melanoma. J Invest Dermatol 126: 2242\u20132246","journal-title":"J Invest Dermatol"},{"key":"1250_CR13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00000658-200001000-00009","volume":"231","author":"H Ueno","year":"2000","unstructured":"Ueno H, Mochizuki H, Hatsuse K, Hase K, Yamamoto T (2000) Ann Surg 231: 59\u201366","journal-title":"Ann Surg"},{"key":"1250_CR14","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/01.sla.0000189131.90876.9e","volume":"242","author":"S Balzan","year":"2005","unstructured":"Balzan S, Belgihiti J, Farges O, Ogata S, Sauvanet A, Delefosse D, et al (2005) The \"50:50 criteria\" on postoperative day 5, an accurate predictor of liver failure and death after hepatectomy. Ann Surg 242: 824\u2013828","journal-title":"Ann Surg"},{"key":"1250_CR15","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1072-7515(99)00089-7","volume":"189","author":"S Iwatsuki","year":"1999","unstructured":"Iwatsuki S, Dvorchik I, Madariaga JR, Marsh JW, Dodson F, Bonham A, et al (1999) Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. J Am Coll Surg 189: 291\u2013299","journal-title":"J Am Coll Surg"},{"key":"1250_CR16","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/(SICI)1097-0142(19960401)77:7<1254::AID-CNCR5>3.0.CO;2-I","volume":"77","author":"B Nordlinger","year":"1996","unstructured":"Nordlinger B, Guiguet M, Vailant J (1996) Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Cancer 77: 1254\u20131262","journal-title":"Cancer"},{"key":"1250_CR17","first-page":"399","volume":"18","author":"B Cady","year":"1991","unstructured":"Cady B, Stone MD (1991) The role of surgical resection of liver metastases in colorectal carcinoma. Semin Oncol 18: 399\u2013406","journal-title":"Semin Oncol"},{"key":"1250_CR18","first-page":"67","volume":"29","author":"B Gentner","year":"2009","unstructured":"Gentner B, Wein A, Croner RS, Zeittraeger I, Wirtz RM, Roedel F, et al (2009) Differences in the gene expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in primary colorectal tumors and their synchronous liver metastases. Anticancer Res 29: 67\u201374","journal-title":"Anticancer Res"},{"key":"1250_CR19","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s00508-007-0774-7","volume":"119","author":"L Pleyer","year":"2007","unstructured":"Pleyer L, Went P, Russ G, Primz E, Faber V, Roewert H-J, et al (2007) Massive infiltration of bone marrow in colon carcinoma after treatment with activated protein c. Wien Klin Wochenschr 119: 254\u2013258","journal-title":"Wien Klin Wochenschr"},{"key":"1250_CR20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/SLA.0b013e3180603039","volume":"246","author":"S Zakari","year":"2007","unstructured":"Zakari S, Donohue J, Que FG, Farnell MB, Schleck CD, Ilstrup DM, et al (2007) Hepatic resection for colorectal metastases. Ann Surg 246: 183\u2013191","journal-title":"Ann Surg"},{"key":"1250_CR21","doi-asserted-by":"crossref","unstructured":"Ichikawa A, Kotake K, Matsui T, Koyama Y, Suda K, Yao T (2009) Classification of colorectal carcinoma obtained from the combination of DNA ploidy and genetic alterations serves as a significant prognostic factor. J Gastroenterol e-Pub ahead of print [April 8th, 2009]","DOI":"10.1007\/s00535-009-0035-9"},{"key":"1250_CR22","first-page":"1271","volume":"29","author":"K Riemann","year":"2009","unstructured":"Riemann K, Struwe H, Alakus H, Obermaier B, Schmitz KJ, Schmid KW, et al (2009) Association of GNBA intro-1 haplotypes with survival in patients with UICC stage III and IV colorectal carcinoma. Anticancer Res 29: 1271\u20131274","journal-title":"Anticancer Res"},{"key":"1250_CR23","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/ijc.24441","volume":"125","author":"P McColgan","year":"2009","unstructured":"McColgan P, Sharma P (2009) Polymorphisms of matrix metalloproteinase 1, 2, 3 and 9 and susceptibility to lung, breast and colorectal cancer in over 30,000 subjects. Int J Cancer Int J Cancer 125: 1473\u20131478","journal-title":"Int J Cancer Int J Cancer"},{"key":"1250_CR24","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/107327480701400313","volume":"14","author":"CM Rocha-Lima","year":"2007","unstructured":"Rocha-Lima CM, Soares H, Raez LE, Singal R (2007) EGFR targeting of solid tumors. Cancer Control 14: 295\u2013304","journal-title":"Cancer Control"},{"key":"1250_CR25","first-page":"1192","volume":"34","author":"H Takiuchi","year":"2007","unstructured":"Takiuchi H (2007) Cetuximab. Gan To Kagaku Ryoho 34: 1192\u20131195","journal-title":"Gan To Kagaku Ryoho"},{"key":"1250_CR26","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1158\/1541-7786.MCR-06-0404","volume":"5","author":"J Tabernero","year":"2007","unstructured":"Tabernero J (2007) The role of VEGF and EGFR inhibition: implications for combining anti-VEGF and anti-EGFR agents. Mol Cancer Res 5: 203\u2013220","journal-title":"Mol Cancer Res"},{"key":"1250_CR27","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/978-3-540-46091-6_8","volume":"176","author":"J Stoehlmacher","year":"2007","unstructured":"Stoehlmacher J (2007) Prediction of efficacy and side effects of chemotherapy in colorectal cancer. Recent Results Cancer Res 176: 81\u201388","journal-title":"Recent Results Cancer Res"},{"key":"1250_CR28","doi-asserted-by":"crossref","unstructured":"Russo A, Corsale S, Cammareri P, Agnese V, Cascio S, di Fede G, et al (2005) Pharmacogenomics in colorectal carcinomas: future perspectives in personalized therapy. J Cell Physiol: 742\u2013749","DOI":"10.1002\/jcp.20357"},{"key":"1250_CR29","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1245\/ASO.2006.03.060","volume":"13","author":"S Yoon","year":"2006","unstructured":"Yoon S, Kim S, Gonen M, Heffernan N, Detwiller K, Jarnagin W, et al (2006) Profile of plasma angiogenic factors before and after hepatectomy for colorectal cancer liver metastases. Ann Surg Oncol 13: 353\u2013362","journal-title":"Ann Surg Oncol"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-009-1250-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00508-009-1250-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-009-1250-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T01:53:19Z","timestamp":1559094799000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00508-009-1250-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":29,"journal-issue":{"issue":"19-20","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["1250"],"URL":"https:\/\/doi.org\/10.1007\/s00508-009-1250-3","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}